Gene · 5733
Papers2,527
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,527
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Experimental simulation of symmetry-protected higher-order exceptional points with single photons. | Sci Adv | 2023 | 37611104 | PubTator, text mining | PubMed |
| The severity of NEC is ameliorated by prostaglandin E2 through regulating intestinal microcirculation. | Sci Rep | 2023 | 37591866 | PubTator, text mining | PubMed |
| Rice-produced classical swine fever virus glycoprotein E2 with herringbone-dimer design to enhance immune responses. | Plant Biotechnol J | 2023 | 37572354 | PubTator, text mining | PubMed |
| A novel classifier combining G protein-coupled receptors and the tumor microenvironment is associated with survival status in glioblastoma. | Front Pharmacol | 2023 | 37560473 | PubTator, text mining | PubMed |
| Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors. | Cancer Res Commun | 2023 | 37559947 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| Evaluating the Usefulness and Ease of Use of a Next-Generation-Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals' Perceptions. | JMIR Hum Factors | 2023 | 37531173 | PubTator, text mining | PubMed |
| Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Bioinformatics and Next-Generation Sequencing Data Analysis. | Bioinform Biol Insights | 2023 | 37529485 | PubTator, text mining | PubMed |
| A potential correlation between adipokines, skeletal muscle function and bone mineral density in middle-aged and elderly individuals. | Lipids Health Dis | 2023 | 37525169 | PubTator, text mining | PubMed |
| Prorelaxant E-type Prostanoid Receptors Functionally Partition to Different Procontractile Receptors in Airway Smooth Muscle. | Am J Respir Cell Mol Biol | 2023 | 37523713 | PubTator, text mining | PubMed |
| Inhibitory effects of NSAID-conjugated SN-38 on the viability of A549 Non-small cell lung cancer cells. | Biochem Biophys Rep | 2023 | 37521373 | PubTator, text mining | PubMed |
| Association of Acetaminophen With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Pharmacologic Considerations and Treatment Options. | Cureus | 2023 | 37519510 | PubTator, text mining | PubMed |
Results of Induction of Labor with Prostaglandins E1 and E2 (The RIPE Study): A Real-World Data Analysis of Obstetrical Effectiveness and Clinical Outcomes of Pharmacological Induction of Labor with Vaginal Inserts. | Pharmaceuticals (Basel) | 2023 | 37513894 | PubTator, text mining | PubMed |
| Drug repurposing screens to identify potential drugs for chronic kidney disease by targeting prostaglandin E2 receptor. | Comput Struct Biotechnol J | 2023 | 37484490 | PubTator, text mining | PubMed |
| Single hormone or synthetic agonist induces Gs/Gi coupling selectivity of EP receptors via distinct binding modes and propagating paths. | Proc Natl Acad Sci U S A | 2023 | 37478163 | PubTator, text mining | PubMed |
| Damage-mediated macrophage polarization in sterile inflammation. | Front Immunol | 2023 | 37465676 | PubTator, text mining | PubMed |
| Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis. | J Med Chem | 2023 | 37458373 | PubTator, text mining | PubMed |
| PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer. | Front Immunol | 2023 | 37457723 | PubTator, text mining | PubMed |
| Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma. | Arch Esp Urol | 2023 | 37455526 | PubTator, text mining | PubMed |
| The Role of Genetics in Preterm Birth. | Reprod Sci | 2023 | 37450251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5733/papers?page=8